Recent Updates
Recently added Catalysts
REGN

Regeneron Announces Upcoming 2015 Investor Conference Presentations

Key Takeaway: Regeneron Announces Upcoming 2015 Investor Conference Presentations

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
VEGF Trap-Eye
Phase 1 · Diabetic Macular Edema

Full Press Release Details

TARRYTOWN, N.Y.,Aug. 31, 2015/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management presentations at the following investor conferences:
• Baird 2015 Healthcare Conference at12:50 p.m. Eastern TimeonWednesday, September 9, 2015
• Morgan Stanley Global Healthcare Conference at12:30 p.m. Eastern TimeonWednesday, September 16, 2015
• Bank of America Merrill Lynch Global Healthcare Conference at10:25 a.m. Eastern TimeonThursday, September 17, 2015
The sessions may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visitwww.regeneron.com.
Contact Information:
Investor Relations Corporate Communications
Manisha Narasimhan, Ph.D. Hala Mirza
914.847.5126 914.847.3422
[email protected] [email protected]
Last updated: Aug 31, 2015